4D Molecular Therapeutics (FDMT) Insider Trading & Ownership $8.41 -0.26 (-3.00%) (As of 11/20/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends 4D Molecular Therapeutics (NASDAQ:FDMT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage7.30%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$16.38 M Get FDMT Insider Trade Alerts Want to know when executives and insiders are buying or selling 4D Molecular Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address FDMT Insider Buying and Selling by Quarter Ad Colonial Metals“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in…>> YES! Send Me My FREE Gold Guide! 4D Molecular Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/16/2024Scott BizilyInsiderSell500$16.33$8,165.00 7/16/2024Scott BizilyInsiderSell1,750$27.11$47,442.50 7/11/2024Scott BizilyInsiderSell1,996$25.00$49,900.00 7/10/2024David KirnCEOSell12,923$22.49$290,638.27 7/1/2024Scott BizilyInsiderSell4,248$21.36$90,737.28 6/24/2024David KirnCEOSell12,930$23.10$298,683.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 5/16/2024Scott BizilyInsiderSell1,750$25.45$44,537.50 4/16/2024Scott BizilyInsiderSell1,750$25.74$45,045.00 4/1/2024Scott BizilyInsiderSell8,153$31.78$259,102.34 3/27/2024Scott BizilyInsiderSell5,833$35.04$204,388.32 3/18/2024Scott BizilyInsiderSell1,750$31.27$54,722.50 2/27/2024Scott BizilyInsiderSell1,909$30.00$57,270.00 2/16/2024Scott BizilyInsiderSell1,750$27.67$48,422.50 2/8/2024David KirnCEOSell92,001$27.13$2,495,987.13 2/8/2024Scott BizilyInsiderSell6,244$27.50$171,710.00 2/5/2024Robert Young KimInsiderSell24,552$30.05$737,787.60 1/23/2024David KirnCEOSell5,696$18.41$104,863.36 1/4/2024David KirnCEOSell40,732$20.31$827,266.92 1/4/2024Global Investors Lp VikingMajor ShareholderSell540,000$19.53$10,546,200.00 (Data available from 1/1/2013 forward) FDMT Insider Trading Activity - Frequently Asked Questions Who is on 4D Molecular Therapeutics's Insider Roster? The list of insiders at 4D Molecular Therapeutics includes David Kirn, Global Investors Lp Viking, Jacob Chacko, Robert Young Kim, and Scott Bizily. Learn more on insiders at FDMT. What percentage of 4D Molecular Therapeutics stock is owned by insiders? 7.30% of 4D Molecular Therapeutics stock is owned by insiders. Learn more on FDMT's insider holdings. Which 4D Molecular Therapeutics insiders have been buying company stock? The following insider purchased FDMT shares in the last 24 months: Global Investors Lp Viking ($13,600,000.00). How much insider buying is happening at 4D Molecular Therapeutics? Insiders have purchased a total of 850,000 FDMT shares in the last 24 months for a total of $13,600,000.00 bought. Which 4D Molecular Therapeutics insiders have been selling company stock? The following insiders have sold FDMT shares in the last 24 months: David Kirn ($5,389,852.24), Global Investors Lp Viking ($10,546,200.00), Jacob Chacko ($100,250.00), Robert Young Kim ($737,787.60), and Scott Bizily ($1,455,899.41). How much insider selling is happening at 4D Molecular Therapeutics? Insiders have sold a total of 851,291 4D Molecular Therapeutics shares in the last 24 months for a total of $18,229,989.25 sold. 4D Molecular Therapeutics Key ExecutivesDr. John F. Milligan Ph.D. (Age 63)Executive Chairman Compensation: $150kDr. David H. Kirn M.D. (Age 61)Co-Founder, CEO & Director Compensation: $1.01MDr. Fariborz Kamal Ph.D. (Age 61)President & COO Compensation: $786.2kDr. Noriyuki Kasahara M.D. (Age 61)Ph.D., Chief Scientific Officer Compensation: $201.29kDr. Robert Y. Kim M.B.A. (Age 63)M.D., Chief Medical Officer Compensation: $704.84kMs. Theresa Janke (Age 49)Co-Founder & Chief of Staff Compensation: $652.32kMr. Uneek Mehra (Age 52)Chief Financial & Business Officer Dr. Scott P. Bizily J.D. (Age 51)Ph.D., Chief Legal Officer & Corporate Secretary Dr. An Song Ph.D.Chief Development OfficerDr. Alan H. Cohen FAAAAI (Age 63)FAAP, FACAAI, FCCP, M.D., Senior VP & Therapeutic Area Head of Pulmonology More Insider Trading Tools from MarketBeat Related Companies KNSA Insider Trades SYRE Insider Trades TVTX Insider Trades OCUL Insider Trades DAWN Insider Trades PRAX Insider Trades SNDX Insider Trades SPRY Insider Trades RCUS Insider Trades NTLA Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:FDMT) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 4D Molecular Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share 4D Molecular Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FDMT Stock Alerts